Metropolis
-
{
- All
- News
- Videos
- Web Stories
-
Garden Reach Shipbuilders, Nuvama, Metropolis Dividends: Last Day To Buy Shares To Qualify — Details Here
Garden Reach Shipbuilders' board had announced an interim dividend of Rs 5.75 per share.
-
LIC, Mankind Pharma, Aurobindo Pharma, Godrej Properties, Birlasoft, Metropolis, Symphony & More Q2 Review
HDFC Securities recommends 'Add' rating for LIC, Aurobindo Pharma, Star Cement, Metropolis, Godrej Properties 'Buy' Symphony, Astral, 'Reduce' Alkyl Amines, Clean Science - here's why
-
'Core Diagnostics' Margins In Double Digits By FY26-End': Metropolis Positive On Latest Acquisition
Metropolis Healthcare acquired Delhi-NCR-based Core Diagnostics in late 2024 for a total consideration of Rs 247 crore.
-
Apollo Hospitals, Metropolis Among ICICI Securities' Top Picks In Healthcare Pack; Q2 Results Preview
Healthcare Q2 Results Preview: ICICI Securities names Apollo Hospitals, Jupiter Life Line, and Metropolis as top picks in the healthcare services sector.
-
Metropolis Healthcare Q2 Updates: Revenue Rises 23% Due To Momentum In Preventive Health Check-Ups
Metropolis Healthcare's business-to-consumer revenue grew at 16% year-on-year.
-
Metropolis Healthcare Q1 Results: Profit Soars 19%, Margin Contracts
Revenue soared 23% to Rs 386.06 crore during the quarter ended June 30.
-
Buy Sun Pharma, Add Metropolis Lists HDFC Securities Among Others In Pharma, Healthcare; Q1 Results Preview
Overall, HDFC Securities expects strong performances from Lupin, Ipca, and Torrent, while Aurobindo, Zydus, and Max Healthcare may post muted results.
-
Metropolis Healthcare Q1 Update: Revenue Up 23%
Revenues grew approximately 13% YoY due to an increase in patient and test volumes.
-
Eicher Motors, GAIL, Metropolis, Hero MotoCorp, Jubilant FoodWorks, Westlife Foodworld & More Q4 Review
HDFC Securities recommends 'Buy' rating for GAIL India, Hero MotoCorp, ITD, Syrma 'Add' Eicher Motors, Shree Cement, Max Financial, Jubilant FoodWorks, Metropolis, 'Reduce' Westlife Foodworld
-
Pharma, Healthcare Q4 Results Preview: FY25 To End With Steady Growth, Better Margin, Says HDFC Securities
HDFC Securities foresees strong performances from Lupin, Ipca Labs, and Apollo Hospital, while Aurobindo and Max Healthcare may show muted results.
-
Metropolis Healthcare To Acquire DAPIC For Over Rs 35 Crore
Metropolis Healthcare to acquire DAPIC for over Rs 35 cr
-
Pharma Dodges First Round Of US Tariff Risk; Sun Pharma, Lupin, Ipca Among HDFC Securities' Top Picks
This no-tariff-impact after the first round will be a positive for the entire pharma sector, Sun Pharma, Lupin, and domestic focused companies like Torrent Pharma, Ipca remains DRChoksey's top pick
-
Metropolis Healthcare Chairperson Ameera Shah Takes Over As NATHEALTH President
Metropolis Healthcare Chairperson Ameera Shah elected NATHEALTH President
-
Metropolis Healthcare Aims To Boost North India Presence With Agra Diagnostic Chain Acquisition
Agra’s leading diagnostic chain Scientific Pathology is the second acquisition by Metropolis Healthcare in north India in the last three months.
-
Metropolis Healthcare Aims To Boost North India Presence With Agra Diagnostic Chain Acquisition
Agra’s leading diagnostic chain Scientific Pathology is the second acquisition by Metropolis Healthcare in north India in the last three months.
-
Garden Reach Shipbuilders, Nuvama, Metropolis Dividends: Last Day To Buy Shares To Qualify — Details Here
Garden Reach Shipbuilders' board had announced an interim dividend of Rs 5.75 per share.
-
LIC, Mankind Pharma, Aurobindo Pharma, Godrej Properties, Birlasoft, Metropolis, Symphony & More Q2 Review
HDFC Securities recommends 'Add' rating for LIC, Aurobindo Pharma, Star Cement, Metropolis, Godrej Properties 'Buy' Symphony, Astral, 'Reduce' Alkyl Amines, Clean Science - here's why
-
'Core Diagnostics' Margins In Double Digits By FY26-End': Metropolis Positive On Latest Acquisition
Metropolis Healthcare acquired Delhi-NCR-based Core Diagnostics in late 2024 for a total consideration of Rs 247 crore.
-
Apollo Hospitals, Metropolis Among ICICI Securities' Top Picks In Healthcare Pack; Q2 Results Preview
Healthcare Q2 Results Preview: ICICI Securities names Apollo Hospitals, Jupiter Life Line, and Metropolis as top picks in the healthcare services sector.
-
Metropolis Healthcare Q2 Updates: Revenue Rises 23% Due To Momentum In Preventive Health Check-Ups
Metropolis Healthcare's business-to-consumer revenue grew at 16% year-on-year.
-
Metropolis Healthcare Q1 Results: Profit Soars 19%, Margin Contracts
Revenue soared 23% to Rs 386.06 crore during the quarter ended June 30.
-
Buy Sun Pharma, Add Metropolis Lists HDFC Securities Among Others In Pharma, Healthcare; Q1 Results Preview
Overall, HDFC Securities expects strong performances from Lupin, Ipca, and Torrent, while Aurobindo, Zydus, and Max Healthcare may post muted results.
-
Metropolis Healthcare Q1 Update: Revenue Up 23%
Revenues grew approximately 13% YoY due to an increase in patient and test volumes.
-
Eicher Motors, GAIL, Metropolis, Hero MotoCorp, Jubilant FoodWorks, Westlife Foodworld & More Q4 Review
HDFC Securities recommends 'Buy' rating for GAIL India, Hero MotoCorp, ITD, Syrma 'Add' Eicher Motors, Shree Cement, Max Financial, Jubilant FoodWorks, Metropolis, 'Reduce' Westlife Foodworld
-
Pharma, Healthcare Q4 Results Preview: FY25 To End With Steady Growth, Better Margin, Says HDFC Securities
HDFC Securities foresees strong performances from Lupin, Ipca Labs, and Apollo Hospital, while Aurobindo and Max Healthcare may show muted results.
-
Metropolis Healthcare To Acquire DAPIC For Over Rs 35 Crore
Metropolis Healthcare to acquire DAPIC for over Rs 35 cr
-
Pharma Dodges First Round Of US Tariff Risk; Sun Pharma, Lupin, Ipca Among HDFC Securities' Top Picks
This no-tariff-impact after the first round will be a positive for the entire pharma sector, Sun Pharma, Lupin, and domestic focused companies like Torrent Pharma, Ipca remains DRChoksey's top pick
-
Metropolis Healthcare Chairperson Ameera Shah Takes Over As NATHEALTH President
Metropolis Healthcare Chairperson Ameera Shah elected NATHEALTH President
-
Metropolis Healthcare Aims To Boost North India Presence With Agra Diagnostic Chain Acquisition
Agra’s leading diagnostic chain Scientific Pathology is the second acquisition by Metropolis Healthcare in north India in the last three months.
-
Metropolis Healthcare Aims To Boost North India Presence With Agra Diagnostic Chain Acquisition
Agra’s leading diagnostic chain Scientific Pathology is the second acquisition by Metropolis Healthcare in north India in the last three months.
